Results 181 to 190 of about 59,772 (269)
ABSTRACT Background Atopic dermatitis (AD) is characterised by immune dysregulation and skin‐barrier dysfunction, which can predispose to microbial dysbiosis and skin infections. Fungi, particularly Malassezia, are common skin colonisers in AD patients and may exacerbate the condition.
Luis F. Andrade+8 more
wiley +1 more source
The Impact of Anesthesia on Dermatological Outcomes: A Narrative Review. [PDF]
Islam RK+6 more
europepmc +1 more source
Designing diversity: ethical virtual agents for effective dermatological training
Melisa Kujević+4 more
openalex +1 more source
ABSTRACT Background Atopic dermatitis (AD) is a chronic, immune‐mediated, inflammatory skin disorder affecting a heterogeneous population. Most patients with mild‐to‐moderate AD are treated with topical medication. Objectives To gain an understanding of the management of mild‐to‐moderate AD with topical treatments by examining the practices of ...
Lawrence F. Eichenfield+14 more
wiley +1 more source
Verrucous psoriasis and current treatments: a review of the literature. [PDF]
Rahman SM+4 more
europepmc +1 more source
ABSTRACT Eosinophilic pneumonia (EP) involves the accumulation of eosinophilic infiltrates in the lung parenchyma, potentially triggered by smoking, infections, or medications, including biologics for psoriasis. This case report describes a 49‐year‐old female with a history of psoriasis and chronic pancreatitis, who developed EP after initiating ...
Katie K. Lovell, Steven R. Feldman
wiley +1 more source
Pityriasis Rubra Pilaris Following COVID-19 Infection: A Case of Successful Treatment With Ixekizumab. [PDF]
Ross MN, Snider WT, Depew I, Cook S.
europepmc +1 more source
ABSTRACT Background Cutaneous Crohn's disease (CCD) is a granulomatous condition of the skin discontiguous from the gastrointestinal tract. Cutaneous disease rarely correlates with intestinal disease and often requires separate treatment. While the use of interleukin‐12/23 (IL‐12/IL‐23) and interleukin‐23 (IL‐23) inhibitors is FDA‐approved for ...
G. E. McKay+14 more
wiley +1 more source
Diagnosis and Management of Skin Toxicities in Systemic Treatment of Genitourinary Cancers. [PDF]
Chowdhury D+11 more
europepmc +1 more source